Long-term velaglucerase alfa treatment in children with Gaucher disease type 1 naïve to enzyme replacement therapy or previously treated with imigluceraseLaurie D. Smith, Gregory M. Pastores, Ashish Bavdekar et al.|Molecular Genetics and Metabolism|2015Cited by 38
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnoverSteffi Oesterreich, David A. Flockhart, N. Lynn Henry et al.|Breast Cancer Research and Treatment|2015Cited by 35